The Ivy Brain Tumor Center located at the Barrow Neurological Institute is a non-profit translational science project established through a $50 million investment from the Ben & Catherine Ivy Foundation in collaboration with the Barrow Neurological Foundation. This represents the most substantial individual research endowment in the field of brain tumor studies globally. Our research initiative is specifically dedicated to identifying novel treatments for brain tumor patients by conducting a diverse range of pharmacodynamic- and pharmacokinetic-driven clinical trials, integrating drug development in partnership with the largest operative brain tumor volume in the country.